Apeiron RIA LLC Sells 1,728 Shares of The Clorox Company (NYSE:CLX)

Apeiron RIA LLC trimmed its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 51.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,648 shares of the company's stock after selling 1,728 shares during the quarter. Apeiron RIA LLC's holdings in Clorox were worth $268,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Mizuho Securities USA LLC grew its holdings in Clorox by 46,877.8% during the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company's stock valued at $733,095,000 after purchasing an additional 4,490,421 shares during the period. Ilex Capital Partners UK LLP grew its stake in shares of Clorox by 512.7% during the 3rd quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company's stock worth $88,315,000 after acquiring an additional 453,624 shares during the period. International Assets Investment Management LLC increased its holdings in Clorox by 424.9% in the 3rd quarter. International Assets Investment Management LLC now owns 538,576 shares of the company's stock worth $877,390,000 after acquiring an additional 435,971 shares during the last quarter. Boston Trust Walden Corp raised its stake in Clorox by 5,442.5% in the 3rd quarter. Boston Trust Walden Corp now owns 273,908 shares of the company's stock valued at $44,622,000 after acquiring an additional 268,966 shares during the period. Finally, Assenagon Asset Management S.A. lifted its holdings in Clorox by 302.0% during the fourth quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company's stock valued at $57,390,000 after purchasing an additional 265,455 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

CLX has been the subject of a number of analyst reports. Barclays cut their price target on Clorox from $139.00 to $130.00 and set an "underweight" rating for the company in a report on Friday, January 17th. Wells Fargo & Company raised Clorox from an "underweight" rating to an "equal weight" rating and lifted their target price for the company from $155.00 to $157.00 in a report on Tuesday, January 7th. Evercore ISI lowered their price target on shares of Clorox from $140.00 to $139.00 and set an "underperform" rating on the stock in a report on Monday, October 14th. StockNews.com cut shares of Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. Finally, DA Davidson increased their target price on shares of Clorox from $153.00 to $171.00 and gave the stock a "neutral" rating in a research note on Monday, November 4th. Four investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, Clorox currently has a consensus rating of "Hold" and a consensus price target of $156.54.

Clorox Trading Down 1.1 %

Shares of CLX stock traded down $1.71 during trading hours on Friday, reaching $159.12. The company's stock had a trading volume of 948,374 shares, compared to its average volume of 787,854. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The stock has a market capitalization of $19.70 billion, a P/E ratio of 55.44, a P/E/G ratio of 2.92 and a beta of 0.42. The firm's fifty day simple moving average is $163.66 and its 200 day simple moving average is $157.32. The Clorox Company has a one year low of $127.60 and a one year high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.36 by $0.50. The business had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company's quarterly revenue was up 27.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.49 EPS. Equities research analysts expect that The Clorox Company will post 6.87 EPS for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.07%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox's dividend payout ratio is presently 170.04%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.